A Prospective Randomized and Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Pembrolizumab (Primary) ; Aldesleukin; Cyclophosphamide; Fludarabine
- Indications Malignant melanoma
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 17 Jun 2016 Status changed from suspended to recruiting.
- 12 Apr 2016 Status changed from recruiting to suspended.